Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles ...

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...

Masimo will partner with Google to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Google smartwatches.

1. Published clinical studies on pulse oximetry and the benefits of Masimo SET ® can be found on our website at www.masimo.com. Comparative studies include independent and objective studies which ...

Masimo Corporation (NASDAQ:MASI) disclosed Friday that it received unsolicited offers from potential acquirers for its ...

Details How Independent Third Parties and the Evidence in Legal Proceedings Have Consistently Refuted Masimo’s "Defensive ... (the "Annual Meeting"), set for September 19. The full text of ...

Apart from focusing on its consumer business separation, Masimo continues to expand its product portfolio. Earlier this month ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing ...

Masimo Corp.’s annual shareholder meeting, scheduled for Sept. 19, will determine whether Joe Kiani will remain as chairman of the company he co-founded in 1989. The Irvine maker of non-invasive ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...